Oral 544 Wilding

A randomised, phase II, placebo- and active-controlled dose-ranging study of semaglutide for treatment of obesity in subjects without diabetes

  View PDF

Poster T4P9 Van Gaal

The effect of semaglutide on liver enzymes in subjects with obesity and elevated alanine aminotransferase: data from a randomised phase 2 study

  View PDF

Poster T4PLB2 Wharton

Real-world clinical effectiveness of liraglutide 3.0 mg for weight management in Canada

  View PDF

Poster T4P118 Wilding

High number of responders with pharmacotherapy-induced weight loss of at least 15% in a placebo-controlled, dose-ranging study of semaglutide in subjects with obesity

  View PDF

Poster T4PLB4 Macklin

Perceptions of barriers to effective obesity management in Canada: results from the ACTION Study

  View PDF

Presentation schedule

Novo Nordisk scientific material 2018: complete ECO pdf

  View PDF